Solid Malignancies research hub

A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

This study is testing a new medicine, CT7439, for people with solid tumours (cancers). Doctors want to see if it's safe and how well it works, both by itself and with other cancer treatments. It's an early-stage study to find the right dose.